
MusclePharm is an American nutritional supplement company founded in 2006 and headquartered in Las Vegas, Nevada. The company has been involved in several controversies and legal issues, including a lawsuit by NSF International for unauthorized use of NSF certification marks, patent infringement claims, and accusations of selling products with unauthorized ingredients. MusclePharm has also faced investigations by the Securities and Exchange Commission (SEC) for accounting and disclosure violations, as well as issues with celebrity endorsements, such as the termination of their deal with Arnold Schwarzenegger, which led to a lawsuit by Capstone Nutrition.
| Characteristics | Values |
|---|---|
| Year founded | 2006 |
| Headquarters | Las Vegas, Nevada |
| Founder | Brad Pyatt |
| First President and CFO | Sabina Rizvi |
| Current CEO | Eric Hillman |
| Products | Banned substance-tested, nutritional supplements |
| Product issues | Smaller servings, higher prices, poor quality, amino acid spiking, NSF certification mark misuse |
| Lawsuits | ThermoLife, Tawnsaura Group, Capstone Nutrition, Inter-Mountain Capital, John's Lone Star Distribution, Hi-Tech Pharmaceuticals |
| Investigation | U.S. Securities and Exchange Commission |
Explore related products
What You'll Learn

Arnold Schwarzenegger ends his deal with MusclePharm
Arnold Schwarzenegger has officially ended his partnership with sports nutrition brand MusclePharm, the company behind the Arnold Schwarzenegger Series. Schwarzenegger's spokesman, Daniel Ketchell, said:
> After collaborating with MusclePharm for the past three years on the Arnold Series, given the distractions caused by the significant issues that MusclePharm faces, Arnold believes that the time is right for him to move on and pursue other opportunities with partners that are better suited to help him fulfill his ultimate vision to promote fitness around the world.
The collaboration between Schwarzenegger and MusclePharm lasted three years and was filled with low-quality products and lawsuits. The Arnold Schwarzenegger Series quickly became synonymous with MusclePharm's lowest-quality products. For instance, Iron Whey was extremely cheap, tasted awful, and was originally loaded with glycine and taurine (i.e. amino acid spiked). Iron Mass was the product that got the company sued for amino acid spiking, and a serving of Iron Cre3 had just 1g of creatine nitrate, which is 22.3% of the lowest daily research-backed dose of creatine.
MusclePharm has faced a multitude of issues, including a class action suit alleging the company sold products with a new dietary ingredient lacking FDA approval, accusations in the European Union that a product bearing Schwarzenegger's name was spiked with a weight-loss drug deemed "highly toxic" by the FDA, and a Securities and Exchange Commission investigation into six-figure perks granted to executives. The company was also sued by NSF for unauthorized use of its certification seal in 2013, and by ThermoLife for patent infringement on amino acid compounds.
MusclePharm was first incorporated in 2006 and is headquartered in Las Vegas, Nevada. It is a publicly traded company.
Neck Muscles: Their Existence and Significance
You may want to see also
Explore related products

NSF sues MusclePharm for using certification mark without authorisation
MusclePharm Corporation, an American nutritional supplement company, was sued by NSF International in December 2013 for improperly using the "NSF Certified for Sport" mark on one of its products. NSF declared that MusclePharm was not authorised to use any NSF certification marks, claim that its products were NSF-certified, or assert that they were manufactured in an NSF Good Manufacturing Practices (GMP)-certified or registered facility.
The "NSF Certified for Sport" mark is a third-party certification program recognised by major sports organisations like the US Anti-Doping Agency, Major League Baseball, the National Hockey League, and the Canadian Football League. It is designed to help athletes, dieticians, coaches, and consumers make safer choices when selecting sports supplements, as products are tested for 280+ banned substances.
MusclePharm's use of the NSF certification mark without authorisation may have misled consumers into believing that its products had undergone the rigorous testing and safety standards associated with the NSF certification. This could have had significant implications for athletes and others who rely on certified supplements to ensure they are not inadvertently consuming banned or unsafe substances.
The lawsuit against MusclePharm highlights the importance of proper certification and transparency in the nutritional supplement industry. It serves as a reminder to consumers to be vigilant about the products they use and to seek out reliable sources for their health and fitness needs.
Elliptical Workouts: Burning Fat, Not Muscle
You may want to see also
Explore related products
$28.99

MusclePharm sued for patent infringement
MusclePharm, an American nutritional supplement company, has faced several legal issues, including a lawsuit for patent infringement. The company was sued by ThermoLife, which claimed that MusclePharm infringed on its patent related to amino acid compounds, including creatine nitrate. This was not the only legal issue that MusclePharm has faced. The company was also charged by the U.S. Securities and Exchange Commission (SEC) for various accounting and disclosure violations. The SEC investigation revealed that MusclePharm failed to report or misrepresented approximately $500,000 in benefits paid to executives and chairmen. Additionally, MusclePharm was found to have issued stock without the necessary registration statements when entering into transactions with third parties.
The Tawnsaura Group also sued MusclePharm for patent infringement, although the specifics of this case are not publicly available. These lawsuits have been a significant challenge for MusclePharm, impacting its reputation and potentially resulting in financial penalties. The company has also faced other legal issues, including a suit from John's Lone Star Distribution, which alleged that MusclePharm entered into illegal price discrimination contracts to remove Lone Star from the market.
The Environmental Research Center (ERC) has also filed a notice of intent to initiate litigation against MusclePharm and over 200 other nutrition and supplement companies, alleging violations of California Proposition 65. The details of this case are not yet clear, but it further adds to the legal troubles faced by MusclePharm. In addition to these legal challenges, MusclePharm has also faced scrutiny for its business practices. In 2013, NSF International notified the public that a MusclePharm product improperly used the "NSF Certified for Sport" mark. As a result, NSF launched a lawsuit against MusclePharm, stating that the company was not authorized to use any NSF certification marks or claim that its products were manufactured in an NSF GMP-certified facility.
The lawsuit with NSF International and the SEC charges highlight potential issues with MusclePharm's internal processes and quality control. These incidents have likely impacted the company's reputation and may have led to increased scrutiny from regulators and consumers. In addition to the legal and business challenges, MusclePharm has also faced criticism for its financial dealings. In 2016, the company sold BioZone, which it had acquired in 2013, to Flavor Producers for $9.8 million. This sale raised questions, as it was done to generate funds to pay off outstanding invoices to vendors, totaling approximately $1.1 million.
Muscle Deterioration: What's Happening to My Body?
You may want to see also
Explore related products

MusclePharm's accounting and disclosure violations
MusclePharm, an American nutritional supplement company, has been charged with several accounting and disclosure violations by the U.S. Securities and Exchange Commission (SEC). The SEC investigation found that MusclePharm failed to report or misrepresented approximately $500,000 in benefits paid to current or former executives and chairmen. The investigation also revealed that MusclePharm had issued stock without a registration statement when it entered into transactions with third parties, exchanging company shares for cash payments to vendors. This resulted in MusclePharm owing vendors approximately $1.1 million in outstanding invoices.
The SEC charged former MusclePharm executives, including the Executive Vice President of Sales and Operations, Brian H. Casutto, the former Vice President of Sales, Matthew J. Zucco, and the former contract Chief Financial Officer, Kevin R. Harris, with improper revenue recognition practices. The investigation found that these executives engaged in a scheme to prematurely recognize revenue for orders still under MusclePharm's control, inflating the company's quarterly revenues by up to 25% and gross profits by up to 49%.
Additionally, the SEC charged MusclePharm's former CEO, Ryan C. Drexler, with disclosure violations, control failures, and violating the clawback provision of the Sarbanes-Oxley Act of 2002. Drexler was accused of demanding revenue growth, which led to the improper revenue recognition practices. The SEC sought injunctive relief, civil penalties, reimbursement to MusclePharm, and an officer and director bar as part of the litigation.
The accounting and disclosure violations had far-reaching consequences for MusclePharm. The company agreed to pay a fine of $700,000 and hire an independent monitor for one year. Additionally, MusclePharm's CEO, Brad Pyatt, was charged, and the company faced lawsuits from various entities, including Inter-Mountain Capital, John's Lone Star Distribution, and Protein supplement maker Hi-Tech Pharmaceuticals.
Understanding Rope Muscle Development: Causes and Prevention
You may want to see also
Explore related products

MusclePharm's illegal price discrimination contracts
MusclePharm, an American nutritional supplement company, has faced a range of legal issues since its founding in 2006. One notable issue was a lawsuit brought by John's Lone Star Distribution, which alleged that MusclePharm engaged in illegal price discrimination practices.
John's Lone Star Distribution, a MusclePharm distributor, claimed that the company entered into illegal price discrimination contracts with a Lone Star competitor. The intention, according to the lawsuit, was to remove Lone Star from the market. This type of practice, where a seller charges different prices to competing buyers for the same product, is known as "primary line" injury and may violate the Robinson-Patman Act.
The Robinson-Patman Act prohibits price discrimination that causes injury to competitors. In this case, the allegation was that MusclePharm offered more favourable pricing to Lone Star's competitor, giving them an unfair advantage in the market. This type of price discrimination can be particularly damaging to smaller businesses, as it can drive them out of business or force them to sell their company, as was the case with Lone Star.
While price discriminations are generally lawful, they can become illegal under certain circumstances. For example, if a firm charges below-cost sales in one locality while charging higher prices in another and plans to recoup lost profits, it may be violating the Robinson-Patman Act. Similarly, offering promotional allowances or services that are not available to all customers on equal terms may also constitute a violation.
MusclePharm has faced other legal troubles, including a lawsuit by the U.S. Securities and Exchange Commission (SEC) for accounting and disclosure violations, as well as lawsuits by other companies for breach of contract, patent infringement, and artificial inflation of protein levels in their products. These issues have damaged MusclePharm's reputation and resulted in significant financial consequences.
Muscle Tissue and Calorie Burn: What's the Truth?
You may want to see also
Frequently asked questions
MusclePharm Corporation is an American nutritional supplement company founded in 2006 in Denver, Colorado, and headquartered in Las Vegas, Nevada.
In 2013, NSF International launched a lawsuit against MusclePharm for falsely claiming that its products were NSF-certified. In the same year, the company was investigated by the U.S. Securities and Exchange Commission (SEC) for accounting and disclosure violations, which led to its founder Brad Pyatt stepping down. In 2016, Arnold Schwarzenegger, who had endorsed a line of products, also severed ties with the company. Since then, MusclePharm has faced various lawsuits and financial troubles.
No, but he did end his relationship with the company, and his name was associated with some of MusclePharm's lowest-quality and controversial products.













![COLOSSAL LABS Muscle Protein Whey Powder [12 lbs/Pack of 1]– Cold Filtered, 25g Pure Protein, 6.6g BCAAs (Packaging May Vary) (12LB, Peanut Butter Chocolate)](https://m.media-amazon.com/images/I/81Lf5lxm7RL._AC_UL320_.jpg)





























